P5 - Plenary Session V: Enabling pharmaceutical policies and the case for investment in primary health care

Meeting room: Avicenna

Rapporteur: Rida Himmet, Vice Secretary General, Turkish Pharmacist’ Association, Turkey


Harun Kizilay, Vice President, Turkish Medicines and Medical Devices Agency, Turkey and Catherine Duggan, CEO, FIP, The Netherlands


The first and second day of the conference will demonstrate the needs, barriers and opportunities for pharmacists in the primary health care setting. This session will explore how pharmaceutical policies should enable the next leap forward for pharmacists in providing primary health care services and what investment these policies imply for realising the vision for the future of the profession


09:00 – 09:10     Introduction by chairs

09:10 – 09:30     The role of pharmacists in interprofessional teams in primary health care

Kemal Buharalioglu, Professor, Katip Celebi University, Faculty of Pharmacy, Turkey

09:30 – 09:50    Overview of the legal and regulatory framework for community pharmacies in the WHO European Region

Tifenn Humbert, Technical Officer, Health Technologies and Pharmaceuticals

Division of Health Systems and Public Health, WHO Regional Office for Europe, Denmark

09:50 – 10:10     Designing effective primary health care systems in Europe

Frederico Guanais, Deputy Head of the Health Division , ELS/Health Division, Organisation for Economic Co-operation and Development (OECD), France

10:10 – 11:00   Panel discussion with questions from the audience